about
PcMab-47: Novel Antihuman Podocalyxin Monoclonal Antibody for Immunohistochemistry.Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma.Prognostic role of podocalyxin-like protein expression in various cancers: A systematic review and meta-analysis.Podocalyxin influences malignant potential by controlling epithelial-mesenchymal transition in lung adenocarcinoma.Keratan Sulphate, a complex Glycosaminoglycan with Unique Functional Capability.Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis.Conservation of oncofetal antigens on human embryonic stem cells enables discovery of monoclonal antibodies against cancer
P2860
Q33600992-01AB85AF-9FC9-4B6E-8545-8079567B98E4Q36091414-6C4E5B44-FD16-4435-A388-F74945A040B6Q36236781-03FB7B7B-D82E-46E6-9D53-05D82D322A09Q37735632-945106B8-ADB3-4DA7-A78E-F048FC32B07CQ47860795-099E8683-D513-4276-A223-520DA5B9C85DQ52688319-B6015FD3-719C-4B52-866A-9623D9253E38Q58803669-6A8BD34A-DD3D-477D-9CB3-2100BCFA237A
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Podocalyxin as a Prognostic Marker in Gastric Cancer
@ast
Podocalyxin as a Prognostic Marker in Gastric Cancer
@en
type
label
Podocalyxin as a Prognostic Marker in Gastric Cancer
@ast
Podocalyxin as a Prognostic Marker in Gastric Cancer
@en
prefLabel
Podocalyxin as a Prognostic Marker in Gastric Cancer
@ast
Podocalyxin as a Prognostic Marker in Gastric Cancer
@en
P2093
P2860
P1433
P1476
Podocalyxin as a Prognostic Marker in Gastric Cancer
@en
P2093
Alli Laitinen
Arto Kokkola
Caj Haglund
Christian Fermér
Olle Nilsson
P2860
P304
P356
10.1371/JOURNAL.PONE.0145079
P407
P577
2015-12-16T00:00:00Z